Marc J. C. Wilson
Net Worth

Last updated:

What is Marc J. C. Wilson net worth?

The estimated net worth of Mr. Marc J. C. Wilson is at least $11,052,934 as of 26 Sep 2024. He owns shares worth $3,359,422 as insider, has earned $6,638,072 from insider trading and has received compensation worth at least $1,055,440 in Crinetics Pharmaceuticals, Inc. and Appian Corporation.

What is the salary of Marc J. C. Wilson?

Mr. Marc J. C. Wilson salary is $527,720 per year as Chief Financial Officer & Sec. in Crinetics Pharmaceuticals, Inc..

How old is Marc J. C. Wilson?

Mr. Marc J. C. Wilson is 46 years old, born in 1979.

What stocks does Marc J. C. Wilson currently own?

As insider, Mr. Marc J. C. Wilson owns shares in one company:

Company Title Shares Price per share Total value
Crinetics Pharmaceuticals, Inc. (CRNX) Chief Financial Officer & Sec. 111,092 $30.24 $3,359,422

What does Crinetics Pharmaceuticals, Inc. do?

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat carcinoid syndrome and nonfunctional neuroendocrine tumors (NETs). The company is also developing CRN04777, an oral selective nonpeptide somatostatin type 5 receptor agonist, which is in phase I clinical trial for the treatment of congenital hyperinsulinism; and CRN04894, an oral adrenocorticotrophic hormone antagonist that is in phase I clinical trial for the treatment of Cushing's and congenital adrenal hyperplasia diseases. Crinetics Pharmaceuticals, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

CRNX logo
CRNX
Crinetics Pharmaceuticals, Inc.
$30.24

Marc J. C. Wilson insider trading

Crinetics Pharmaceuticals, Inc.

Mr. Marc J. C. Wilson has made 8 insider trades between 2023-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 32,129 units of CRNX stock on 28 Jun 2024. As of 26 Sep 2024 he still owns at least 111,092 units of CRNX stock.

Transaction Date Security Shares Price per share Total value Source
Option
Stock option (Right to Buy) 25,000 $15.29 $382,250
Sale
Common Stock 25,000 $51.11 $1,277,750
Option
Common Stock 25,000 $15.29 $382,250
Option
Stock option (Right to Buy) 19,056 $9.28 $176,840
Option
Common Stock 19,056 $9.28 $176,840
Sale
Common Stock 19,056 $53.88 $1,026,737
Option
Common Stock 25,000 $20.02 $500,500
Option
Stock option (Right to Buy) 25,000 $20.02 $500,500
Sale
Common Stock 25,000 $55 $1,375,000
Sale
Common Stock 32,129 $43.61 $1,401,146
Option
Stock option (Right to Buy) 32,129 $9.28 $298,157
Option
Common Stock 32,129 $9.28 $298,157
Sale
Common Stock 6,942 $42.91 $297,881
Sale
Common Stock 10,000 $35.47 $354,700
Option
Common Stock 10,000 $9.28 $92,800
Option
Non-qualified stock option (Right to Buy) 10,000 $9.28 $92,800
Sale
Common Stock 10,000 $28.75 $287,500
Option
Non-qualified stock option (Right to Buy) 10,000 $9.28 $92,800
Option
Common Stock 10,000 $9.28 $92,800
Option
Non-qualified stock option (Right to Buy) 20,000 $9.28 $185,600
Option
Common Stock 20,000 $9.28 $185,600
Sale
Common Stock 30,922 $19.97 $617,358

Crinetics Pharmaceuticals key executives

Crinetics Pharmaceuticals, Inc. executives and other stock owners filed with the SEC:

  • Dr. Ajay Madan DABT, Ph.D., D.A.B.T. (57) Chief Devel. Officer
  • Dr. R. Scott Struthers (63) Founder, Pres, Chief Executive Officer & Director
  • Mr. Marc J. C. Wilson (46) Chief Financial Officer & Sec.